These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 602249)

  • 1. Identification of an N-oxide as the major metabolite of the analgesic O-(diethylaminoethyl)-4-chlorobenzaldoxime hydrochloride in dogs.
    Kirkpatrick D; Weston KT; Hawkins DR; Chasseaud LF; Elsom LF
    Xenobiotica; 1977 Dec; 7(12):747-55. PubMed ID: 602249
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolites of 2-(3-trifluoromethylphenyl)tetrahydro-1,4-oxazine (CERM) 1841) in rats and dogs.
    Kucharczyk N; Yang JT; Valia KH; Stiefel FJ; Sofia RD
    Xenobiotica; 1979 Nov; 9(11):703-11. PubMed ID: 532219
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolism of labetalol by animals and man.
    Martin LE; Hopkins R; Bland R
    Br J Clin Pharmacol; 1976 Aug; 3(4 Suppl 3):695-710. PubMed ID: 990152
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The disposition of radioactivity after administration of the anthelminthic methyl-14C-5-cyclopropylcarbonyl-2-benzimidazole carbamate (ciclobendazole) to rats and dogs.
    Brodie RR; Mayo BC; Chasseaud LF; Hawkins DR
    Arzneimittelforschung; 1977; 27(3):593-8. PubMed ID: 577426
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The absorption, metabolism and excretion of (14C)-AR-L 115 BS in the baboon.
    Cameron BD; Draffan GH; Dunsire JP; Zimmer A
    Arzneimittelforschung; 1981; 31(1a):217-20. PubMed ID: 7195225
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Pharmacokinetics and biotransformation of the analgesic flupirtine in the rat and dog].
    Obermeier K; Niebch G; Thiemer K
    Arzneimittelforschung; 1985; 35(1):60-7. PubMed ID: 4039153
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Pharmacokinetics and biotransformation of the analgesic flupirtine in humans].
    Hlavica P; Niebch G
    Arzneimittelforschung; 1985; 35(1):67-74. PubMed ID: 4039154
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolic fate of the thrombolytic agent benzarone in man: comparison with the rat and dog.
    Wood SG; John BA; Chasseaud LF; Bonn R; Grote H; Sandrock K; Darragh A; Lambe RF
    Xenobiotica; 1987 Jul; 17(7):881-96. PubMed ID: 3660858
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolism and pharmacokinetics of 4-(p-chlorophenylthio)butanol (W-2719) in the rat and dog.
    Kucharczyk N; Edelson J; Sofia RD; Ludwig BJ; Shahinian S; Schuster E; Ballard FH; Yang J; Myers G
    Arzneimittelforschung; 1979; 29(10):1550-6. PubMed ID: 583221
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics of NS-105, a novel cognition enhancer. 1st communication: absorption, metabolism and excretion in rats, dogs and monkeys after single administration of 14C-NS-105.
    Mukai H; Sugimoto T; Ago M; Morino A
    Arzneimittelforschung; 1999 Nov; 49(11):881-90. PubMed ID: 10604039
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The metabolic fate of the coronary vasodilator 4-(3,4,5-Trimethoxycinnamoyl)-1-(N-pyrrolidinocarbonylmethyl)piperazine (cinepazide) in the rat, dog and man.
    Cameron BD; Chasseaud LF; Hawkins DR; Taylor T
    Xenobiotica; 1976 Jul; 6(7):441-55. PubMed ID: 997590
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The absorption and excretion of the peripheral vasodilator 14C-mecinarone, (14C-6809 MD) in rat, dog and man.
    Hawkins DR; Weston KT; Chasseaud LF; Darragh A; O'Kelly A
    Eur J Drug Metab Pharmacokinet; 1980; 5(3):135-43. PubMed ID: 7202431
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Studies on the metabolism of meptazinol, a new analgesic drug.
    Franklin RA; Aldridge A
    Br J Clin Pharmacol; 1976 Jun; 3(3):497-502. PubMed ID: 973975
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The metabolic disposition of 14C-ciramadol in humans.
    Sisenwine SF; Liu AL; Tio C; Kimmel H; Freeland G
    Xenobiotica; 1986 Apr; 16(4):335-40. PubMed ID: 3754997
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolism and excretion of tolcapone, a novel inhibitor of catechol-O-methyltransferase.
    Jorga K; Fotteler B; Heizmann P; Gasser R
    Br J Clin Pharmacol; 1999 Oct; 48(4):513-20. PubMed ID: 10583021
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolism of the anti-depressant lortalamine.
    Elsom LF; Biggs SR; Chasseaud LF; Hawkins DR; Pulsford J; Darragh A
    Eur J Drug Metab Pharmacokinet; 1985; 10(3):209-15. PubMed ID: 4085522
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Excretion and biotransformation of cisapride in dogs and humans after oral administration.
    Meuldermans W; Van Peer A; Hendrickx J; Lauwers W; Swysen E; Bockx M; Woestenborghs R; Heykants J
    Drug Metab Dispos; 1988; 16(3):403-9. PubMed ID: 2900732
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Physiological disposition and metabolism of timolol in man and laboratory animals.
    Tocco DJ; Duncan AE; Delauna FA; Hucker HB; Gruber VF; Vandenheuvel WJ
    Drug Metab Dispos; 1975; 3(5):361-70. PubMed ID: 241617
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolic and pharmacokinetic studies following oral administration of 14C-famciclovir to healthy subjects.
    Filer CW; Allen GD; Brown TA; Fowles SE; Hollis FJ; Mort EE; Prince WT; Ramji JV
    Xenobiotica; 1994 Apr; 24(4):357-68. PubMed ID: 8059539
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics of intravenous and oral 1,2-O-isopropylidene-3-O-3'-(N',N'-dimethylamino-n-propyl)-D-glucofuranose hydrochloride in the dog as a function of dose and characterization of metabolites.
    Garrett ER; Van Peer A
    J Pharm Sci; 1983 Sep; 72(9):1045-57. PubMed ID: 6631692
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.